Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Latest research news and updates

Reflecting on PANORAMIC and PRINCIPLE, three years into the COVID-19 Pandemic

Earlier this month—Saturday 11 March 2023—we marked the third anniversary of the World Health Organization (WHO) declaring the COVID-19 pandemic. This anniversary is an opportunity to reflect on the lessons learned from the pandemic and renew efforts to strengthen health systems and ensure equitable access to vaccines and treatments.

Largest Hindu temple in Europe opens new health hub whilst providing continued support for PANORAMIC and PRINCIPLE trials

Europe’s BAPS Swaminarayan Sanstha, with the Neasden Temple, one of the largest Hindu temples outside of India, has opened a new community health hub in west London. Following their continued support of the PANORAMIC and PRINCIPLE trials, the temple’s interactive health hub will engage visitors around health awareness and wellbeing.

Findings into colchicine published in the British Journal of General Practice

Department Research

Findings from research by the PRINCIPLE Trial into treatment of COVID-19 in the community with the anti-inflammatory drug colchicine published in the British Journal of General Practice.

10,000 people join the PRINCIPLE Trial – A huge ‘Thank You’ from us all.

10,000 people have joined the PRINCIPLE Trial over the last two years and we want to say a big ‘Thank You’ to them all for their amazing contribution to testing treatments for COVID-19 in the community.

PRINCIPLE trial 'highly commended' for innovative use of health data

The PRINCIPLE trial has been highly commended at the Health Data Research UK Awards for the way in which patient data is utilised so participants are contacted about the trial soon after receiving a positive test result.

Ivermectin to be investigated in adults aged 18+ as a possible treatment for COVID-19 in the PRINCIPLE trial

From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. The drug is now available to treat COVID-19 on a case-by-case basis in UK primary care.

Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial

Could the antiviral favipiravir help transform COVID-19 into an illness that can be successfully treated by general practitioners?

PRINCIPLE COVID-19 treatments trial widens to under 50s and adds colchicine

From today, the UK’s national priority platform trial of COVID-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

Azithromycin and doxycycline are not generally effective against COVID-19 in patients treated at home, shows PRINCIPLE trial

Update from the Chief Investigators of the Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE), 25 January 2021

De Montford University Leicester students to support PRINCIPLE trial recruitment

Students from De Montfort University Leicester (DMU) are the first in the country to help drive the PRINCIPLE clinical study to find Covid-19 treatments for the over 50’s that can help speed up recovery.

Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial

Inhaled budesonide is an inexpensive, safe and commonly prescribed treatment for asthma and COPD. It is the fourth medication to be tested in PRINCIPLE.

Two major pharmacy chains join PRINCIPLE Trial

Two of the UK’s largest pharmacy chains, LloydsPharmacy and Well Pharmacy, are tasking their branches with helping to find suitable patients for the PRINCIPLE Trial of Covid-19 treatments.

Britain’s most influential Hindu temple spreads awareness of the PRINCIPLE trial among Indian community

Europe’s BAPS Swaminarayan Sanstha, the largest Hindu temple outside of India, is supporting their community during the coronavirus pandemic by spreading awareness of the PRINCIPLE trial of Covid-19 treatments.

PRINCIPLE Trial of COVID-19 treatments recruits 1000th participant

More than 1000 people across the UK have signed-up to take part in the UK-wide PRINCIPLE Trial of potential community-based treatments for COVID-19, led by Oxford University.

PRINCIPLE Trial to strengthen Black, Asian and minority ethnic community participation

Professor Mahendra G Patel, University of Bradford, joins PRINCIPLE Trial as National Black, Asian and minority ethnic Community and Pharmacy Lead

PRINCIPLE and ZOE partner to widen access to trial

Oxford University and the COVID Symptom Study app are joining forces to widen access to the PRINCIPLE trial of potential treatments for COVID-19.

PRINCIPLE Trial calls on UK primary care to support patient recruitment

Research

The Co-Chief Investigators of the PRINCIPLE Trial, Professor Chris Butler and Professor Richard Hobbs, write an open letter to health professionals across UK primary care calling on their support, so those who are still contracting COVID-19 are given the opportunity to join the trial.

Load More